Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Enhanced detection of circulating tumor DNA by fragment size analysis.

Mouliere F, Chandrananda D, Piskorz AM, Moore EK, Morris J, Ahlborn LB, Mair R, Goranova T, Marass F, Heider K, Wan JCM, Supernat A, Hudecova I, Gounaris I, Ros S, Jimenez-Linan M, Garcia-Corbacho J, Patel K, Østrup O, Murphy S, Eldridge MD, Gale D, Stewart GD, Burge J, Cooper WN, van der Heijden MS, Massie CE, Watts C, Corrie P, Pacey S, Brindle KM, Baird RD, Mau-Sørensen M, Parkinson CA, Smith CG, Brenton JD, Rosenfeld N.

Sci Transl Med. 2018 Nov 7;10(466). pii: eaat4921. doi: 10.1126/scitranslmed.aat4921.

PMID:
30404863
2.

Personalising Treatment for High-Grade Serous Ovarian Carcinoma.

Cojocaru E, Parkinson CA, Brenton JD.

Clin Oncol (R Coll Radiol). 2018 Aug;30(8):515-524. doi: 10.1016/j.clon.2018.05.008. Epub 2018 Jun 19.

PMID:
29934103
3.

Severe steroid-resistant anti-PD1 T-cell checkpoint inhibitor-induced hepatotoxicity driven by biliary injury.

Doherty GJ, Duckworth AM, Davies SE, Mells GF, Brais R, Harden SV, Parkinson CA, Corrie PG.

ESMO Open. 2017 Oct 10;2(4):e000268. doi: 10.1136/esmoopen-2017-000268. eCollection 2017.

4.

Exploratory Analysis of TP53 Mutations in Circulating Tumour DNA as Biomarkers of Treatment Response for Patients with Relapsed High-Grade Serous Ovarian Carcinoma: A Retrospective Study.

Parkinson CA, Gale D, Piskorz AM, Biggs H, Hodgkin C, Addley H, Freeman S, Moyle P, Sala E, Sayal K, Hosking K, Gounaris I, Jimenez-Linan M, Earl HM, Qian W, Rosenfeld N, Brenton JD.

PLoS Med. 2016 Dec 20;13(12):e1002198. doi: 10.1371/journal.pmed.1002198. eCollection 2016 Dec.

5.

Knowledge of Dementia: Do family members understand dementia as a terminal condition?

Andrews S, McInerney F, Toye C, Parkinson CA, Robinson A.

Dementia (London). 2017 Jul;16(5):556-575. doi: 10.1177/1471301215605630. Epub 2015 Sep 21.

PMID:
26394629
6.

Spatial and temporal heterogeneity in high-grade serous ovarian cancer: a phylogenetic analysis.

Schwarz RF, Ng CK, Cooke SL, Newman S, Temple J, Piskorz AM, Gale D, Sayal K, Murtaza M, Baldwin PJ, Rosenfeld N, Earl HM, Sala E, Jimenez-Linan M, Parkinson CA, Markowetz F, Brenton JD.

PLoS Med. 2015 Feb 24;12(2):e1001789. doi: 10.1371/journal.pmed.1001789. eCollection 2015 Feb.

7.

Management of malignant ovarian germ cell tumors.

Parkinson CA, Hatcher HM, Ajithkumar TV.

Obstet Gynecol Surv. 2011 Aug;66(8):507-14. doi: 10.1097/OGX.0b013e318234ede9. Review.

PMID:
22018453
8.

Multidisciplinary management of malignant ovarian germ cell tumours.

Parkinson CA, Hatcher HM, Earl HM, Ajithkumar TV.

Gynecol Oncol. 2011 Jun 1;121(3):625-36. doi: 10.1016/j.ygyno.2010.12.351. Epub 2011 Feb 25.

PMID:
21353692
9.

Mutation of FOXL2 in granulosa-cell tumors of the ovary.

Shah SP, Köbel M, Senz J, Morin RD, Clarke BA, Wiegand KC, Leung G, Zayed A, Mehl E, Kalloger SE, Sun M, Giuliany R, Yorida E, Jones S, Varhol R, Swenerton KD, Miller D, Clement PB, Crane C, Madore J, Provencher D, Leung P, DeFazio A, Khattra J, Turashvili G, Zhao Y, Zeng T, Glover JN, Vanderhyden B, Zhao C, Parkinson CA, Jimenez-Linan M, Bowtell DD, Mes-Masson AM, Brenton JD, Aparicio SA, Boyd N, Hirst M, Gilks CB, Marra M, Huntsman DG.

N Engl J Med. 2009 Jun 25;360(26):2719-29. doi: 10.1056/NEJMoa0902542. Epub 2009 Jun 10.

10.

Management of solid tumours in organ-transplant recipients.

Ajithkumar TV, Parkinson CA, Butler A, Hatcher HM.

Lancet Oncol. 2007 Oct;8(10):921-32. Review.

PMID:
17913661
11.

Improving nursing education classroom environments.

Fisher DL, Parkinson CA.

J Nurs Educ. 1998 May;37(5):232-6.

PMID:
9605201
12.

Aldosterone excretion rates in children and adults during sleep.

Pratt JH, Miller JZ, Fineberg NS, Parkinson CA.

Hypertension. 1986 Feb;8(2):154-8.

PMID:
3002981
13.

Decreases in renin and aldosterone secretion in alloxan diabetes: an effect of insulin deficiency.

Pratt JH, Parkinson CA, Weinberger MH, Duckworth WC.

Endocrinology. 1985 May;116(5):1712-6.

PMID:
3886365
14.

The effect of captopril treatment on potassium-induced stimulation of aldosterone production in vitro.

Parkinson CA, Belton SJ, Pratt JH.

Endocrinology. 1984 May;114(5):1567-70.

PMID:
6370662
15.

Stimulation of aldosterone secretion by metoclopramide in humans: apparent independence of renal and pituitary mediation.

Pratt JH, Ganguly A, Parkinson CA, Weinberger MH.

Metabolism. 1981 Feb;30(2):129-34.

PMID:
6258008
16.

The effect of sodium on aldosterone metabolic clearance.

Pratt JH, Luft FC, Parkinson CA, Rankin LI.

Steroids. 1981 Jan;37(1):1-6.

PMID:
7222140
17.
18.

Increased aldosterone metabolic clearance in hypertensive patients treated with minoxidil: an effect of greater hepatic perfusion.

Pratt JH, Yager CJ, Grim CE, Parkinson CA.

J Cardiovasc Pharmacol. 1980;2 Suppl 2:S236-41.

PMID:
6156360
19.

Minoxidil increases aldosterone metabolic clearance in hypertensive patients.

Pratt JH, Grim CE, Parkinson CA.

J Clin Endocrinol Metab. 1979 Dec;49(6):834-7.

PMID:
511974
20.

A new approach to the difficult assessment of aldosterone secretion in anephric patients.

Pratt JH, Parkinson CA, Luft FC.

Steroids. 1978 Nov;32(4):487-98.

PMID:
214904

Supplemental Content

Loading ...
Support Center